Oruka Therapeutics Inc.
ORKA | NASDAQ
$97.70
+$0.83 (+0.86%)
Nov 2, 2026, 9:55 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -41.21M | -31.82M | -29.58M | -30.28M | -24.57M | -21M | -25.78M | -28.62M | -2.68M | -7.08M | -3.27M | -5.68M | -4.71M | -4.83M | -4.1M |
Depreciation & Amortization | 43K | 43K | 28K | 20K | 19K | 16K | 16K | n/a | 12K | n/a | 28K | 28K | 27K | 19K | 17K |
Stock-Based Compensation | n/a | n/a | n/a | 10.17M | 5.08M | 4.88M | n/a | n/a | n/a | 85K | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -2.75M | 2.03M | 1.42M | 1.97M | -2.71M | -3.12M | 2.14M | 5.93M | -80K | 987K | -1.12M | 588K | 777K | 357K | -1.34M |
Other Non-Cash Items | 6.48M | 6.67M | 3.59M | -908K | -1.38M | -1.74M | 2.97M | -13.58M | 112K | 1K | 169K | 119K | 104K | 133K | 141K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.54M | 1.53M | 3.37M | -602K | -2.29M | -3.03M | 3.98M | 7.34M | -80K | 6.82M | -1.22M | 582K | -289K | 962K | -1.28M |
Operating Cash Flow | -33.15M | -23.58M | -22.59M | -21.6M | -23.15M | -20.87M | -18.82M | -34.86M | -2.63M | -168K | -4.3M | -4.95M | -4.87M | -3.72M | -5.23M |
Capital Expenditures | n/a | -73K | -63K | -99K | -34K | -13K | -18K | -171K | n/a | n/a | -2K | -7K | -14K | -16K | -6K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -490.55M | -90.83M | -100.99M | n/a | -108M | -44.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 79.6M | 76.47M | 79.03M | n/a | 112.89M | 87.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | -122.35M | n/a | n/a | -329.94M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -410.95M | -14.44M | -22.02M | -122.45M | 4.86M | 42.87M | -329.96M | -171K | n/a | n/a | -2K | -7K | -14K | -16K | -6K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 24.98M | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 169.91M | n/a | n/a | -29.92M | 29.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 663.04M | 40.6M | 298K | 169.91M | 109K | n/a | -526K | 450.05M | 14K | 27.91M | n/a | n/a | n/a | n/a | 23.09M |
Net Cash Flow | 218.95M | 2.59M | -44.32M | 25.86M | -18.18M | 22M | -349.3M | 377.59M | -2.62M | 27.74M | -4.3M | -4.95M | -4.88M | -3.74M | 17.86M |
Free Cash Flow | -33.15M | -23.65M | -22.66M | -21.7M | -23.18M | -20.88M | -18.84M | -35.03M | -2.63M | -168K | -4.3M | -4.95M | -4.88M | -3.74M | -5.23M |
Adj. Free Cash Flow | -33.15M | -23.65M | -22.66M | -31.87M | -28.26M | -25.77M | -18.84M | -35.03M | -2.63M | -253K | -4.3M | -4.95M | -4.88M | -3.74M | -5.23M |
Maintenance CapEx | n/a | -43K | -28K | -20K | -19K | -13K | -16K | n/a | n/a | n/a | -2K | -7K | -14K | -16K | -6K |
Growth CapEx | n/a | -30K | -35K | -79K | -15K | n/a | -2K | -171K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -33.15M | -23.62M | -22.62M | -21.62M | -23.16M | -20.88M | -18.83M | -34.86M | -2.63M | -168K | -4.3M | -4.95M | -4.88M | -3.74M | -5.23M |
Add to Watchlist
Select watchlists to add or remove ORKA